Detalhe da pesquisa
1.
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Mol Cancer
; 22(1): 133, 2023 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573301
2.
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma.
NAR Cancer
; 2(3): zcaa012, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32743555
3.
Protocols for Studies on Genetically Engineered Mouse Models in Prostate Cancer.
Methods Mol Biol
; 1786: 195-206, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29786794
4.
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists.
Cell Death Dis
; 9(11): 1081, 2018 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30349042
5.
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy.
Oncotarget
; 7(7): 7885-98, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799286